Literature DB >> 178047

Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.

C Jersild, P Platz, M Thomsen, B Dupont, A Svejgaard, A K Ciongoli, T Fog, P Grob.   

Abstract

In five patients with definite multiple sclerosis and lack of cell-mediated immunity to measles and parainfluenza virus antigens, various immunological parameters were studied before and during transfer factor treatment. The study showed that cell-mediated immunity to measles virus antigen, as evaluated by the leukocyte migration agarose test, could temporarily be restored, using repeated injections of transfer factor pooled from unselected, normal blood donors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178047     DOI: 10.1111/j.1365-3083.1976.tb03000.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  1 in total

1.  Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.